Oxilan
Doctors: Clinton Should Recover Fully From Clot »
"Jan. 2, 2013 -- Medical experts say Secretary of State Hillary Clinton is extremely lucky that her medical team found the blood clot they are now treating with blood thinners.
The rare clot in a vein between her brain and skull was di"...
Read the Doctors: Clinton Should Recover Fully From Clot article »
Oxilan
OXILAN®
(ioxilan (ioxilan (ioxilan) ) ) Injection 300 mgl/mL
OXILAN®
(ioxilan (ioxilan (ioxilan) ) ) Injection 350 mgI/mL
Nonionic Contrast Agents
NOT FOR INTRATHECAL USE
DRUG DESCRIPTION
OXILAN® (ioxilan (ioxilan) ) (loxilan (ioxilan (ioxilan) ) Injection) formulations are stable, aqueous, sterile, and non-pyrogenic solutions for intravascular administration as diagnostic radiopaque media. Ioxilan (ioxilan (ioxilan) ) is designated chemically as N-(2,3-dihydroxypropyl)-N'-(2-hydroxyethyl)-5-[N-(2,3-dihydroxypropyl) acetamido]-2,4,6-triiodoisophthal-amide and has the following structural formula:
 |
The molecular weight of Ioxilan (ioxilan (ioxilan) ) is 791.12 and the organically bound iodine content is 48.1%. loxilan (ioxilan (ioxilan) ) is nonionic and does not dissociate in solution.
Each mL of OXILAN (ioxilan (ioxilan) ) ® (loxilan Injection) 300 mgl/mL provides 623 mg ioxilan.
Each mL of OXILAN® (Ioxilan Injection) 350 mgI/mL provides 727 mg ioxilan.
Each mL of OXILAN® (ioxilan (ioxilan (ioxilan) ) ) solution contains 0.576 mg citric acid anhydrous, 0.561 mg edetate calcium disodium, and a minimum of 0.22 mg (0.01 mEq) sodium. The pH is adjusted to 6.8 (6.0 to 7.5) with sodium hydroxide and carbon dioxide. The solutions contain no preservative.
Pertinent physicochemical data are below. OXILAN® (Ioxilan (ioxilan (ioxilan) ) Injection) is hypertonic compared to plasma (approximately 285 mOsnVkg water).
| Concentration (mgI/mL) | Concentration W/V | |
| 300 | 350 | |
| Measured Osmolality (mOsm/kg water) @ 37°C | 585 | 695 |
| Viscosity (cPs) @ 37°C @ 20°C |
5.1 9.4 |
8.1 16.3 |
| Specific Gravity @ 37°C | 1.303 | 1.372 |
The OXILAN® (ioxilan (ioxilan (ioxilan) ) ) formulations are clear, colorless to pale yellow solutions containing no undissolved solids. Crystallization does not occur at room temperature. OXILAN® (ioxilan (ioxilan (ioxilan) ) ) solutions have osmolalities of 2.1 and 2.4 times that of plasma (285 mOsm/kg water) and are hypertonic under conditions of use.
Last reviewed on RxList: 2/25/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Oxilan Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.
Updated & New
